Revolving Tables Networking Event
March 2, 2017 @ 6:00 pm - 11:00 pm
Revolving Tables is a networking and mentorship event for a cause – hosting roughly 250 young professionals. The 7th annual Revolving Tables dinner and mentorship event will take place on Thursday, March 2, 2017 at 6 pm at the Four Seasons Hotel in Toronto.
Over a 3-course meal, participants have the opportunity to meet other young professionals and engage with renowned Canadian executives and community leaders; we call them our “mentors.” At each course, young professionals rotate tables offering a new and exclusive opportunity to interact with a new mentor.
Our confirmed mentors include distinguished leaders Bonnie Brooks (Hudson’s Bay Company), David Kassie (Canaccord Genuity) and Tim Horton’s President Sami Siddiqui. The mentorship panel will also include Schulich and York University alumni, including Jeff Rosenthal, MBA graduate, Co-Founder and Managing Partner of Imperial Capital.
Since its inception in 2011, Revolving Tables has raised $500,000 to support cancer research for Israel Cancer Research Fund (ICRF).
Special early bird ticket price is available now at http://revolvingtables.com/#event
Israel Cancer Research Fund (ICRF) was founded in 1975 with the goal of finding treatments and cures for all forms of cancer, utilizing the unique benefits Israel’s scientists have to offer. Today, ICRF continues in its mission to harness Israel’s educational and scientific resources in the fight against cancer by providing funds for post-doctoral fellowships for MD’s and PhDs. Since its inception, ICRF has awarded over 2,200 grants valued at over $56 million USD directly to scientists. The following are just some of the accomplishments from ICRF-Funded Scientists:
- The Philadelphia Chromosome – this is the first genetic link to cancer ever discovered, and has led to the development of Gleevec®, a miracle drug for the treatment of chronic myelogynous leukemia. Gleevec® is now used by over 100,000 people worldwide.
- Doxil® – this cancer drug treats ovarian, breast and AIDS-related cancers.